PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
08 Janeiro 2024 - 7:00PM
Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover
Health” or the “Company”), a physician enablement company committed
to bringing access to great healthcare to everyone on Medicare,
today released research demonstrating Clover Assistant’s impact on
medication adherence. The paper, Clover Assistant Use and
Medication Adherence for Common Chronic Conditions, examines the
correlation between Primary Care Physician (PCP) use of Clover
Assistant and levels of adherence to prescribed medications for
common chronic conditions including diabetes, high blood pressure,
and high cholesterol.
The lead author of the study, Dr. Kumar Dharmarajan, Chief
Medical Officer of Clover Assistant, Adjunct Professor at Yale, and
practicing cardiologist said, “Clinicians have no idea if patients
pick up their prescribed medications at the pharmacy. This is a
glaring blindspot. While it may seem simple, letting doctors know
that their patients have not picked up their refills can prompt
conversations to understand the root cause of the non-adherence and
drive meaningful increases in medication fills, as our research
shows. We know that taking medications regularly for chronic health
conditions lowers complications and reduces healthcare costs.”
This is the third retrospective data analysis conducted by the
company to measure the clinical impact of Clover Assistant on the
identification and management of chronic diseases. The previous
analyses focus on the diagnosis, treatment and progression of
Diabetes and Chronic Kidney Disease.
To learn more about Clover Assistant visit:
www.cloverassistant.com
About Clover HealthClover Health (Nasdaq: CLOV)
is a physician enablement company committed to bringing access to
great healthcare to everyone on Medicare. This includes a health
equity-based focus on seniors who have historically lacked access
to affordable, high-quality healthcare. Our strategy is powered by
our software platform, Clover Assistant, which is designed to
aggregate patient data from across the healthcare ecosystem to
support clinical decision-making and improve health outcomes
through the early identification and management of chronic
disease.
Press Contact:Andrew
Still-Baxterpress@cloverhealth.com
Investor Relations Contact:Ryan
Schmidtinvestors@cloverhealth.com
Clover Health Investments (NASDAQ:CLOV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Clover Health Investments (NASDAQ:CLOV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024